Get exclusive money-saving offers and guides
Straight to your inbox
By signing up, you agree to the Finder
Privacy & Cookies Policy
and
Terms of Use, Disclaimer & Privacy Policy.
How to buy Proteomics International Laboratories shares
Own Proteomics International Laboratories shares in just a few minutes.
Investments
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Proteomics International Laboratories Limited is a biotechnology business based in Australia. Proteomics International Laboratories shares (PIQ) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Proteomics International Laboratories has a trailing 12-month revenue of around $2.4 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Proteomics International Laboratories
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Proteomics International Laboratories . Find the share by name or ticker symbol: PIQ. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Proteomics International Laboratories reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Proteomics International Laboratories . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
US stocks
Finder Award
Our top pick for
Cheap broker fees
Finder Award
Our top pick for
Long-term investing
Finder Award
What's in this guide?
- Proteomics International Laboratories key stats
- Compare share trading platforms
- Is Proteomics International Laboratories stock a buy or sell?
- Proteomics International Laboratories performance over time
- Proteomics International Laboratories 's financials
- How volatile are Proteomics International Laboratories shares?
- Does Proteomics International Laboratories pay a dividend?
- Other common questions
Proteomics International Laboratories share price
Use our graph to track the performance of PIQ stocks over time.Proteomics International Laboratories shares at a glance
Information last updated 2021-06-18.
| 52-week range | $0.395 - $1.48 |
|---|---|
| 50-day moving average | $1.0835 |
| 200-day moving average | $1.0004 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.026 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Proteomics International Laboratories stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Proteomics International Laboratories price performance over time
Historical closes compared with the last close of A$1.115
| 1 week (2021-06-15) | 14.95% |
|---|---|
| 1 month (2021-05-21) | -0.89% |
| 3 months (2021-03-22) | -8.23% |
| 6 months (2020-12-22) | 42.95% |
| 1 year (2020-06-22) | 153.41% |
|---|---|
| 2 years (2019-06-21) | 214.08% |
| 3 years (2018-06-22) | 457.50% |
Proteomics International Laboratories financials
| Revenue TTM | $2.4 million |
|---|---|
| Gross profit TTM | $2.7 million |
| Return on assets TTM | -23.92% |
| Return on equity TTM | -37.09% |
| Profit margin | -101.1% |
| Book value | 0.079 |
| Market capitalisation | $109.4 million |
TTM: trailing 12 months
Proteomics International Laboratories share dividends
We're not expecting Proteomics International Laboratories to pay a dividend over the next 12 months.
Proteomics International Laboratories share price volatility
Over the last 12 months, Proteomics International Laboratories 's shares have ranged in value from as little as $0.395 up to $1.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Proteomics International Laboratories 's is 1.0249. This would suggest that Proteomics International Laboratories 's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Proteomics International Laboratories overview
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research, analytical, and consultancy. Proteomics International Laboratories Ltd has a research agreement with the Busselton Population Medical Research Institute to enhance diagnosis and treatment of lung conditions, such as asthma and chronic obstructive pulmonary disease; the Janssen Research & Development, LLC for the research of diabetic kidney and heart disease treatment; and partnership with QIMR Berghofer Medical Research Institute for the detection of oesophageal adenocarcinoma, the primary common form of oesophageal cancer in Australia. The company was founded in 2001 and is based in Perth, Australia.
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to get $120 off Nintendo Switch on Amazon Prime Day
Amazon Australia is selling the Nintendo Switch video game console for $349 during Prime Day - that's over $120 off the RRP.
-
Amazon Prime Day Australia 2021: All the best deals from Day 2
Here are all the best deals from Amazon Prime Day Australia's second day - including the return of dirt-cheap Nintendo Switch consoles.
-
Amazon Prime Day’s best deals on big-ticket items: Up to 46% off
From Segways to stand-up paddleboards, these are the best Prime Day savings on the most expensive items.
-
Nacon RIG 500 Pro HC Gen 2 review: Super comfortable gaming headphones
The Nacon Rig 500 Pro HC headphones have wide console and PC compatibility, Dolby Atmos licensing and a genuinely comfortable design, even for longer gaming sessions.
-
Oppo Find X3 Neo 5G review: Oppo’s better flagship phone
The Oppo Find X3 Neo lacks the utter flagship features of the Find X3 Pro, but you won't miss them, while you will enjoy its lower price point.
-
7 health insurance deals to save you money at tax time
Avoid the MLS tax and get a rebate by taking out health insurance. Here are 7 deals that’ll save you money on your tax returns.
-
Today’s ASX top stocks: Milton Corporation (MLT ↑16.0%), Oneview Healthcare (ONE ↑12.8%)
The 10 biggest movers on the ASX for Tuesday 22 June 2021.
-
Mobile plans are now more expensive, but here’s a hack to save $200 a year
Telstra, Optus and Vodafone keep raising their prices even as the rest of the market is more affordable than ever.
-
Prime Day VR gaming deal: $60 off the Oculus Quest 2
Amazon is selling the standalone Oculus Quest 2 virtual-reality headset for $432.12. You can also score $77 off the 256GB version.
Ask an Expert
